| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 3090.6 | 2882.3 | 2237.6 |
| Other income | 74.6 | 35.5 | 48.4 |
| Total income | 3165.2 | 2917.8 | 2286.0 |
| Profit before exceptional items & tax | 330.6 | 252.8 | 362.6 |
| Exceptional items | -15.5 | -8.8 | -18.4 |
| Profit before tax | 315.2 | 243.9 | 344.2 |
| Net profit | 243.4 | 186.5 | 254.0 |
| Operating margin | 10.0% | 8.4% | 15.1% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -4.20% |
|---|---|
| Net profit, quarter on quarter | +30.50% |
| Revenue, year on year | +38.10% |
| Operating profit, year on year | -18.50% |
| Operating profit, quarter on quarter | +17.80% |
NSE results filing, NSE: MANIPALHOS. Figures extracted from the filing.
Manipal Health Enterprises Ltd: key numbers
- Share price
- ₹700.00
- Market cap
- ₹92,076 Cr
- Revenue (annual)
- ₹10,336 Cr
- Net profit (annual)
- ₹892.3 Cr
- Promoter holding
- 72.08%
- FII holding
- 3.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Manipal Health Enterprises Ltd
All →Manipal Health Enterprises Share Pledge
Manipal Health Enterprises disclosed a Reg 31(1) encumbrance over 17.43% of promoter shares. The pledge secures up to Rs 500 Crore of Claypond NCDs.
- Value
- ₹500.0 Cr
Manipal Health Enterprises Debt & Borrowing: ₹5,310 Cr
Manipal Health Enterprises Ltd has utilized IPO proceeds for the full redemption of its subsidiary's outstanding listed non-convertible debentures. The total nominal value redeemed is Rs. 5,310 Crore.
- Value
- ₹5,310 Cr
Manipal Health Enterprises Annual General Meeting
Manipal Health Enterprises issued a notice for its 16th Annual General Meeting scheduled for September 29, 2026, to transact ordinary and special business.
Manipal Health Enterprises Share Pledge
Promoters of Manipal Health Enterprises Limited created an encumbrance on 23,21,47,755 shares, representing 17.43% stake. This pertains to covenants under financing documents for NCDs worth Rs.500 Crore.
- Value
- ₹500.0 Cr
Manipal Health Enterprises Investor Presentation: Key Takeaways
Manipal Health delivered robust Q1 FY27 results, with revenue growing 38% YoY to INR 3,091 Cr and EBITDA up 26% to INR 749 Cr, driven primarily by volume-led inpatient and outpatient growth.
Manipal Health Enterprises Other Announcement
Manipal Health Enterprises Limited announced the appointment of Price Waterhouse Chartered Accountants LLP as statutory auditor, effective September 29, 2026, following the tenure completion of BSR & Co. LLP.